Samsung Biologics says its product carbon footprint (PCF) system has been validated by Det Norske Veritas (DNV).

Mounjaro sales were $7.4 billion in the quarter, up 110%. Zepbound sales were $4.3 billion, up 123%. Verzenio sales were $1.6 ...

Eisai Co. Ltd. and Shanghai Henlius Biotech Inc. have entered an exclusive commercialization and co-exclusive development and manufacturing license agreement for the anti-PD-1 antibody serplulimab in ...

The U.S. FDA has accepted and granted Priority Review for Pfizer’s supplemental Biologics License Application (sBLA) for HYMPAVZI.

4Q Loss: $1.6 billion (earnings were $411 million 4Q25) ...

AbbVie has submitted applications for a new indication for upadacitinib (RINVOQ) for the treatment of patients living with ...

Revenues up 7% in the quarter despite €801 million loss.

Braveheart Bio is naming Marc Evanchik Chief Scientific Officer (CSO) and appointing Brittany de Temple Senior Vice President ...

“The global API manufacturing market is going through some major changes these days,” says Sean O’Brien, COO, Abzena. He ...

In 2026, some of the key industry trends essential to company success and maintaining stability include long-lasting ...

OXB and Bristol Myers Squibb (BMS) are expanding a partnership regarding manufacture and supply of lentiviral vectors for BMS ...

Driven by the growing prevalence of chronic diseases, the need for convenient and cost-effective drug delivery solutions, and ...